This week in Other Barks & Bites: the UK’s Intellectual Property Office announced a proposed track for SEP license ratemaking in British courts; the Federal Circuit rules that Colibri’s cancellation of claims to methods of deploying heart valves by retraction barred the medical device firm from meeting the doctrine of equivalents; the Ninth Circuit finds that U.S. transportation of an infringing product sold abroad is a use in commerce under Abitron while finding no likelihood of consumer confusion in a nutritional supplement case; Senators question whether training AI tools on copyrighted works should be legal in a hearing on AI and copyright; and more.

Full Article Available Here